ICU pneumonia has mortality rates ranging from 37% to nearly 60% in middle-income countries. In high-income countries, rates range from 16% to 26%
Peer-Reviewed Publication
Updates every hour. Last Updated: 27-May-2026 00:16 ET (27-May-2026 04:16 GMT/UTC)
A scientific review published today in the NEJM Evidence journal, coordinated by the D’Or Institute for Research and Education (IDOR), evaluated outcomes of adults with community-acquired pneumonia (CAP) admitted to intensive care units (ICUs) in middle-income countries.
In contrast to high-income countries, where mortality ranges from 16% to 26%, the study found significantly higher rates in the countries analyzed. The work brought together 52 studies and approximately 48,707 patients, revealing an overall mortality rate of 37.1%, which increased to 59.3% among patients requiring respiratory support.
Published in Energy Research & Social Science, the study analyzed 686 large-scale solar facilities that went online between January 2022 and November 2023. Researchers found that 56% of projects fell into “no” or “low” conflict categories, while 19% saw high levels of conflict.
Reflective practice is often seen as a golden standard in teacher development. This philosophical critique, drawing on Foucault and Aristotle, shows that reflection has been disenchanted from an antique ethics of care of the self into a secularised epistemology, a techne for production, and even a neoliberal governance technology. The authors call for re‑enchanting reflective practice as phronesis that is a three‑dimensional virtue ethics and for teacher flourishing as students' in loco parentis.
This four-paper Series and accompanying comments examine the growing but under-recognised burden of chronic liver disease in Europe, with a focus on steatotic liver disease, including metabolic dysfunction-associated steatotic liver disease, and alcohol-related liver disease, along with viral hepatitis B and C. The Series provides country-level data on MASLD policies, analyses systemic failures in prevention, timely detection, and equitable access to care across diverse populations and health systems; and evaluates policy gaps, health system responses, and innovations in diagnostics, care models, and public health strategies. The Series calls for the rapid integration of metabolic liver health into non-communicable disease frameworks, strengthened surveillance and care pathways, and coordinated, equity-driven, and preventative approaches to identify the “missing millions” and reduce the rising human and economic toll of chronic liver disease across the region.